1H Results Worse Than Our Expectations, Cut TP and Maintain Sell
|
|
- Beatrice Perry
- 5 years ago
- Views:
Transcription
1 : Sihuan Pharmaceuticals (00460 HK) Johnson Sun 孙凤强 公司报告 : 四环医药 (00460 HK) johnson.sun@gtjas.com.hk 1H Results Worse Than Our Expectations, Cut TP and Maintain Sell 上半年业绩差于我们的预期, 下调目标价, 维持卖出评级 GTJA Research 国泰君安研究 1H2012 results worse than our expectations. Revenue grew by 40.3% YoY, due to changes in revenue recognition methods (while bearing more selling expenses), meaningless. Reported operating profit grew by 19.5% YoY, but if excluding the non-recurring other incomes (mainly government s subsidies), actual operating profit dropped by 11%. Similarly, reported net profit grew by 21.2% YoY to RMB461 mn but recurring net profit dropped by about 10% excluding government s subsidies. Reported net profit accounted to 49% of our previous 2012 full year estimates. But the retreat of core net profit is much worse than our expectations, disappointing. Sales of major products dropped. Sales volume of Cinepazide Maleate (Kelinao and Anjieli) started retreating in 1H2012, just as our expectations. However, changes in revenue recognition has greatly hided the drop. Sales of another key product, Oudimei, dropped by 17% YoY, or 8% HoH. The drop may indicate that its substantial M&A deal of Dupromise (mainly for the product of Oudimei) is based on an unreasonably high valuation. Cut net profit estimates by 9%, 24% and 27% for to RMB 848 mn, RMB851 mn and RMB963 mn. Cut TP to HK$2.00 and maintain Sell rating. While we do not encourage short-sell, we doubt its share price may be affected by similar concerns on its previous acquisitions as well as its growth outlook, not suitable for long-term investment for now. 上半年业绩差于我们的预期 由于收入确认方法改变 ( 公司承担更多的销售费用 ), 收入同比增长 40.3%, 无实际意义 报告的经营利润同比增长 19.5%, 但如果去除非经常性收益 ( 主要是政府补贴 ), 实际经营利润同比下跌 11% 类似的, 净利润同比增长 21.1% 至 4.61 亿元人民币, 但如果扣除政府补贴, 核心净利润同比下跌 10% 上半年净利润占到我们之前全年预测的 49%, 但核心净利润的倒退大幅差于我们的预期, 令人失望 主要产品销售下滑 马来酸桂哌奇特 ( 克林澳和安捷利 ) 的销售量于上半年开始下跌, 符合预期 收入确认方法的改变, 较大程度上掩盖了其下跌 另一个主要产品欧迪美的收入同比下跌 17%, 环比下跌 8%, 可能显示其当时对多菲制药的重大收购 ( 主要收购的产品是欧迪美 ) 或基于较高的代价 分别削减 年的净利润预测 9%,24% 和 27% 至 RMB8.48 亿 RMB8.51 亿和 RMB9.63 亿元 削减目标价至 2.00 港元, 并维持 卖出 评级 虽然我们不建议卖空获利, 但我们担心其股价或会因为对其过往收购及未来增长前景的担忧而受到影响, 认为目前并不适合长期投资 Rating: Sell Maintained 评级 : 卖出 ( 维持 ) 6-18m TP 目标价 : HK$2.00 Share price 股价 : Stock performance 股价表现 (5.0) (10.0) (15.0) (20.0) % of return (25.0) Sep-11 Nov-11 Feb-12 May-12 Aug-12 Change in Share Price 股价变动 HSI Index Sihuan Pharm 1 M 1 个月 3 M 3 个月 HK$ M 12 个月 Abs. % 绝对变动 % Rel. % to HS index 相对恒指变动 % Avg. share price(hk$) 平均股价 ( 港元 ) Source: Bloomberg, Guotai Junan International Year End Turnover Net Profit EPS EPS PER BPS PBR DPS Yield ROE 年结 收入 股东净利 每股净利 每股净利变动 市盈率 每股净资产 市净率 每股股息 股息率 净资产收益率 12/31 (RMB m) (RMB m) (RMB) ( %) (x) (RMB) (x) (RMB) (%) (%) 2010A 1, A 2, F 2, F 3, F 3, Shares in issue (m) 总股数 (m) 5,175 Major shareholder 大股东 Plenty Gold 53.1% Market cap. (HK$ m) 市值 (HK$ m) 16,457 Free float (%) 自由流通比率 (%) month average vol. 3 个月平均成交股数 ( 000) 8,661 FY12 Net gearing (%) FY12 净负债 / 股东资金 (%) Net Cash 52 Weeks high/low (HK$) 52 周高 / 低 / Source: the Company, Guotai Junan International. See the last page for disclaimer Page 1 of 5
2 1H2012 results worse than our expectations. Revenue grew by 40.3% YoY, due to changes in revenue recognition methods (while bearing more selling expenses), meaningless. Reported operating profit grew by 19.5% YoY, but if excluding the non-recurring other incomes (mainly government s subsidies), actual operating profit dropped by 11%. Similarly, reported net profit grew by 21.2% YoY to RMB461 mn but according to our calculations, its recurring net profit dropped by about 10% excluding government s subsidies. Reported net profit accounted to 49% of our previous 2012 full year estimates (Click to download the previous ). But the retreat of core net profit is much worse than our expectations, disappointing. Sales of major products dropped. Sales volume of Cinepazide Maleate (Kelinao and Anjieli) started retreating in 1H2012, just as our expectations. However, changes in revenue recognition has greatly hided the drop. Sales of another key product, Oudimei, dropped by 17% YoY, or 8% HoH. The drop may indicate that its substantial M&A deal of Dupromise (mainly for the product of Oudimei) is based on an unreasonably high valuation. Outlook beyond 1H2012 Concerns on Adverse Drug Reaction (ADR) of Cinepazide Maleate. ADR of Cinepazide Maleate has been a major concern since IPO of Sihuan. We did not realize the seriousness until we read an academic paper, Cinepazide-induced hematological adverse reactions: review and analysis by Dr. Yi Zhanmiao and et al. published on Adverse Drug Reaction Journal on Aug The research suggested that Cinepazide is liable to decrease leckocyte, franulocyte, and platelet, and clinical cinepazide use should be followed by a careful hematological monitoring. According to our phone interview with Dr. Yi, who works in Department of Pharmacy, Peking University Third Hospital, Cinepazide Maleate prescriptions started declining in 2012 in her hospital. We expect the trend may extend to other hospitals in the future, because 1) there are several other substitutes for Cinepazide Maleate, and these substitutes may have less ADR, 2) doctors tend to protect themselves more and keep away from any possible medical disputes. Furthermore, we may expect regulations may have been aware of the use restrictions of Cinepzaide Maleate in other countries, and have initiated similar restrictions in China (which could explain that Cinepazide Maleate was added into the National Medical Insurance Catalog designating for non-ccv disease uses). Inadequate visibility of pipeline products. We reevaluated the R&D and pipeline products of Sihuan, and find that Sihuan has few pipeline products due to short history in R&D. Three major innovative drug R&D projects, including Apapenem, Tylerdipine Hydrochloride and Phencynonate Hydrochloride, are just in pre-clinical trial phase or Phase I or II of clinical trials. We think there are uncertainties for these projects, especially when SFDA s new drug approval has become much more difficult than before. We do not expect the generic R&D projects to be growth drivers, because 1) Cinepazide Masilate also have the similar ADR concerns as Cinepazide Maleate, 2) market of Roxatidine Injection, one of its generic drug project pending for production licenses, is expected to be not large enough, and Sihuan is not good at marketing of digestive drugs, 3) licenses of Nalmefene Hydrochloride, another generic drug of Sihuan, have been approved to four other large manufactures, including Haisike( CH) and Lijun (02005 HK), and Sihuan may not be as competitive as them. Earnings estimates and rating Cut net profit estimates from RMB 936 mn to RMB848 mn (or 9%) in We simply assume the 2H2012 operation is just as good as 1H2012, and double its core earnings for the year. In 2H2012, we expect the Company will book another non-recurring income of about RMB100 mn for the stake disposal of Wansheng Lianhe ( 万生联合 ) to Shandong Buchang ( 山东步长 ). Excluding the non-recurring items, its operating profit and net profit is expected to drop by 18.7% and 16.1% for 2012, respectively. Based on simple assumptions of 1) 10% YoY in top-line for 2013 and 2014 and 2) RMB80 mn and RMB110 mn net profit contributions from Shandong Buchang JV in 2013 and 2014, we roughly estimates net profit of the Company to be RMB851 mn and RMB963 mn, reflecting 24% and 27% cut from our previous estimates. These simple assumptions are subjected to be reviewed in details in our follow-up in-depth research report. Cut TP to HK$2.00 and maintain Sell rating. While we do not encourage short-sell, we doubt its share price may be affected by similar concerns on its previous acquisitions as well as its growth outlook, not suitable for long-term investment for now. See the last page for disclaimer Page 2 of 5
3 Table-1: Key fundamentals of Sihuan s 1H2012 results (RMB) yoy (RMB) Turnover 1,389 mn 40.3% Interim DPS Shareholder s Profit mn 21.2% Payout Ratio 35% EPS 元 21.2% Sources: the Company, Guotai Junan International. Table-2: SWOT summary of Sihuan Strengths 1. It is the largest CCV medicine company in terms of market share in China, taking 9.4% of the total market share in It has a rich product portfolio of CCV medicines, of which, major products such as Anjieli, Kelinao and Oudimei are all exclusive products with little risks of price cut. 3. Management of the Company is very familiar with the hospital channels in China. Opportunities 1. The pharmaceutical industry of China is going integration, good for large companies such as Sihuan. 2. The CCV medicine market is increasing faster than the total pharmaceutical market in China, because of 1) rising morbidity rate of CCV diseases and 2) increasing disposable income in China. 3. The cash position of the Company makes it possible for future acquisitions. Sources: Guotai Junan International. Weaknesses 1. The R&D capability still needs to be improved. 2. Transparency of the Company needs to be improved. Investors may need more comparable information. 3. Lack of blockbusters and growth drivers in the future. Threats 1. Changes in government policies, including 1) drug price cut and tendering, and 2) public hospital reform may affect the profitability of the Company. 2. Changes in revenue recognition may affect the current relationship with its distributors. See the last page for disclaimer Page 3 of 5
4 Financial Statements and Ratios P&L (RMB mn) 2010A 2011A 2012F 2013F 2014F Cash Flow (RMB mn) 2010A 2011A 2012F 2013F 2014F Net revenue 1,037 2,242 2,779 3,056 3,362 Profit before tax 635 1,045 1,117 1,056 1,188 Cost of sales (292) (528) (636) (699) (769) Depreciation and Amortisation Gross profit 745 1,714 2,143 2,357 2,593 Interest income (24) (56) (128) (141) (155) Other adjustment (116) S&D expenses (57) (632) (1,175) (1,293) (1,422) Change in working capital (15) (465) (502) (338) (430) Administrative expenses (129) (201) (251) (276) (303) Tax paid (136) (215) (241) (229) (253) Operating profit Cash flow from operations Other income Finance income, net Purchase of PPE (108) (359) (400) (300) (200) Gains from JV M&A (236) (1,779) (1,200) (300) (300) Profit before income tax 635 1,045 1,117 1,056 1,188 Interest income Income tax expense (128) (245) (241) (229) (253) Others (39) (779) Profit after tax Cash flow from investment (364) (2,863) (1,472) (419) (305) Minority interests (15) (24) 28 (25) (28) Free cash flow 16 (2,150) (1,089) Net profit Recurring net profit Equity raised / (repaid) 5,396 (35) EPS (RMB) Debt raised / (repaid) 0 (11) DPS(RMB) Dividends paid (174) (502) (660) (326) (352) Yield 11.6% 6.1% 1.9% 2.0% 2.3% Others 0 (0) Cash flow from financing 5,222 (548) (660) (326) (352) Balance Sheet (RMB mn) 2010A 2011A 2012F 2013F 2014F Cash and equivalents 5,851 3,153 1,404 1,178 1,051 Cash at yr beginning 613 5,851 3,153 1,404 1,178 Accounts receivable ,024 1,333 1,699 Net Change in Cash 5,239 (2,698) (1,749) (226) (126) Inventories Cash at yr end 5,851 3,153 1,404 1,178 1,051 Others 0 1, Current assets 6,165 5,074 2,685 2,800 3,105 Growth (%) 2010A 2011A 2012F 2013F 2014F Revenue Long-term investments Operating profit (18.7) PPE ,069 1,241 Net Profit Intangible assets 153 3,080 4,272 4,390 4,479 Recurring Net Profit (16.1) Other non-current assets EPS Total non-current assets 738 3,780 5,473 5,870 6,133 Margins (%) 2010A 2011A 2012F 2013F 2014F Total assets 6,902 8,854 8,158 8,670 9,239 Gross margin (%) Operating margin (%) Trade and other payables Net margin (%) Short-term loans 108 1, Other current liabilities Ratios 2010A 2011A 2012F 2013F 2014F Total Current liabilities 233 1, Inventory turnover (x) Receivable turnover (x) Non-current liabilities Payable turnover (x) Total liabilities 243 1, Net debt / equity (%) (87.9) (43.8) (74.2) (71.3) (71.3) ROA (%) Shareholders' equity 6,657 6,946 7,500 7,996 8,557 ROE (%) Non-Controlling interests Valuation 2010A 2011A 2012F 2013F 2014F Total liabilities and equity 6,902 8,854 8,112 8,641 9,211 P/B (x) BVPS (RMB) P/E (x) Source: the Company, Guotai Junan International. See the last page for disclaimer Page 4 of 5
5 Company Rating Definition The Benchmark: Hong Kong Hang Seng Index Time Horizon: 6 to 18 months Rating Definition Buy Relative Performance >15%; or the fundamental outlook of the company or sector is favorable. Accumulate Relative Performance is 5% to 15%; or the fundamental outlook of the company or sector is favorable. Neutral Relative Performance is -5% to 5%; or the fundamental outlook of the company or sector is neutral. Reduce Relative Performance is -5% to -15%; or the fundamental outlook of the company or sector is unfavorable. Sell Relative Performance <-15%; or the fundamental outlook of the company or sector is unfavorable. Sector Rating Definition The Benchmark: Hong Kong Hang Seng Index Time Horizon: 6 to 18 months Rating Definition Outperform Relative Performance >5%; or the fundamental outlook of the sector is favorable. Neutral Relative Performance is -5% to 5%; or the fundamental outlook of the sector is neutral. Underperform Relative Performance <-5%; or the fundamental outlook of the sector is unfavorable. DISCLOSURE OF INTERESTS (1) The Analysts and their associates do not serve as an officer of the issuer mentioned in this Research Report. (2) The Analysts and their associates do not have any financial interests in relation to the issuer mentioned in this Research Report. (3) Except for Shandong Chenming Papers Holdings Limited-H shares (01812) and China City Railway Transportation Technology Holdings Company Limited (08240), Guotai Junan and its group companies do not hold equal to or more than 1% of the market capitalization of the issuer mentioned in this Research Report. (4) Guotai Junan and its group companies have not had investment banking relationships with the issuer mentioned in this Research Report within the preceding 12 months. DISCLAIMER This Research Report does not constitute an invitation or offer to acquire, purchase or subscribe for securities by Guotai Junan Securities (Hong Kong) Limited ("Guotai Junan"). Guotai Junan and its group companies may do business that relates to companies covered in research reports, including investment banking, investment services and etc. (for example, the placing agent, lead manager, sponsor, underwriter or invest proprietarily). Any opinions expressed in this report may differ or be contrary to opinions or investment strategies expressed orally or in written form by sales persons, dealers and other professional executives of Guotai Junan group of companies. Any opinions expressed in this report may differ or be contrary to opinions or investment decisions made by the asset management and investment banking groups of Guotai Junan. Though best effort has been made to ensure the accuracy of the information and data contained in this Research Report, Guotai Junan does not guarantee the accuracy and completeness of the information and data herein. This Research Report may contain some forward-looking estimates and forecasts derived from the assumptions of the future political and economic conditions with inherently unpredictable and mutable situation, so uncertainty may contain. Investors should understand and comprehend the investment objectives and its related risks, and where necessary consult their own financial advisers prior to any investment decision. This Research Report is not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation or which would subject Guotai Junan and its group companies to any registration or licensing requirement within such jurisdiction Guotai Junan Securities (Hong Kong) Limited. All Rights Reserved. 27/F., Low Block, Grand Millennium Plaza, 181 Queen s Road Central, Hong Kong. Tel.: (852) Fax: (852) Website: See the last page for disclaimer Page 5 of 5
Gas Sales Prospect Remains Bright, Maintain Buy
: Binhai Investment (02886 HK) Kevin Guo 郭勇 公司报告 : 滨海投资 (02886 HK) +86 755 23976671 kevin.guo@gtjas.com Gas Sales Prospect Remains Bright, Maintain Buy 天然气销售前景光明, 维持 买入 评级 GTJA Research 国泰君安研究 The 2015
More informationMining Could Bring Positive Surprise in 2017, Maintain Accumulate
Infrastructure Sector Equity Research Report Company Report Equity Research 股票研究公司报告证券研究报告 Company Report: Gary Wong 黄家玮 公司报告 : 中国中铁 (39 HK) +852 259 2616 gary.wong@gtjas.com.hk Mining Could Bring Positive
More informationNatural Gas Sales Growth to Accelerate, Maintain Buy
股票研究 Equity Research : Binhai Investment (02886 HK) Kevin Guo 郭勇公司报告 : 滨海投资 (02886 HK) +86 755 23976671 kevin.guo@gtjas.com Natural Gas Sales Growth to Accelerate, Maintain Buy 天然气销售增速将会加快, 维持 买入 评级 公司报告证券研究报告清洁能源行业
More information2018 Interim Results Beat Expectations, Maintain "Buy"
- Clean Energy Sector-Natural Gas Equity Research 股票研究 Company Report: 公司报告 : 北京控股 (392 HK) Kevin Guo 郭勇 (86755) 2397 6671 kevin.guo@gtjas.com 218 Interim Results Beat Expectations, Maintain "Buy" 218
More informationMetal Prices Under Pressure, Maintain "Neutral"
CMOC (3993 HK) Nonferrous Metals Sector Equity Research 股票研究 Company Report: CMOC (3993 HK) 公司报告 : 洛阳钼业 (3993 HK) [Table_Summary] Metal Prices Under Pressure, Maintain "Neutral" 金属价格承压, 维持 中性 评级 Kevin
More information2017 Annual Results Beat Expectations, Maintain Accumulate
Zijin Mining (02899 HK) Precious Metals Sector Equity Research 股票研究 Company Report: Zijin Mining (02899 HK) 公司报告 : 紫金矿业 (02899 HK) Kevin Guo 郭勇 (86755) 2397 6671 kevin.guo@gtjas.com [Table_Summary] 2017
More informationWeak 1Q16 Results, Neutral 2016 年第一季业绩疲弱, 中性
GTJA Research 国泰君安研究 Company Report: COSCO Pacific (01199 HK) Ivan Zhou 周一帆 公司报告 : 中远太平洋 (01199 HK) +86 755 23976685 zhouyifan013593@gtjas.com Weak 1Q16 Results, Neutral 2016 年第一季业绩疲弱, 中性 Shareholders
More information1H17 Results In Line, Accumulate
- Samsonite (01910 HK) Consumer Sector - Retailing Equity Research 股票研究 : Samsonite (01910 HK) 公司报告 : 新秀丽 (01910 HK) 1H17 Results In Line, Accumulate 2017 年上半年业绩符合预期, 收集 Terry Hong 洪学宇 (86755) 2397 6722
More informationBenign Prospective Fundamentals with Strong Contracted Sales, Reiterate "Buy"
股 票 研 究 公 司 报 告 证 券 研 究 报 告 房 地 产 行 业 Equity Research Property Sector Equity Research Report : Longfor Properties (00960 HK) Van Liu 刘斐凡 公司报告 : 龙湖地产 (00960 HK) +86 755 23976672 liufeifan@gtjas.com Benign
More informationRapid Growth for 1Q18 Power Generation, "Accumulate" 2018 年 1 季度发电量维持高速增长, 收集
- Datang Renewable (01798 HK) Clean Energy Sector - Wind & Others Equity Research 股 票 研 究 公 司 报 告 证 券 研 究 报 告 清洁能源行业 风电及其它 大唐新能源 Equity Research Report Company Report Company Report: Datang Renewable (01798
More information2016 Results above Expectations, Neutral
Cement and Construction Materials Sector Equity Research 股票研究 Company Report: Ray Zhao 赵睿 公司报告 : 金隅股份 (02009 HK) +86 755 23976755 zhaorui@gtjas.com 2016 Results above Expectations, Neutral 2016 年业绩超预期,
More informationPossible Effects from Slower Weibo User Growth, "Buy"
Equity Research Report Internet Sector Equity Research 股 票 研 究 公 司 报 告 证 券 研 究 报 告 互联网行业 : 公司报告 : 新浪 (SINA US) Possible Effects from Slower Weibo User Growth, "Buy" 或受微博增速放缓的影响, 买入 Sina s 1Q18 results
More informationResults Need Time to Improve, Low Valuation, Maintain "Buy"
Modern Land (01107 HK) Property Sector Equity Research 股票研究公司报告证券研究报告 Equity Research Report Company Report Company Report: Modern Land (01107 HK) 公司报告 : 当代置业 (01107 HK) Van Liu 刘斐凡 (86755) 2397 6672 liufeifan@gtjas.com
More informationManagement Buyout Offer at HK$6.30 Per Share, Sell
Belle Int l (01810 HK) Equity Research Report Equity Research 股票研究 : Terry Hong 洪学宇 公司报告 : 百丽国际 (01880 HK) +86 755 23976722 hongxueyu@gtjas.com Management Buyout Offer at HK$6.30 Per Share, Sell 管理层收购要约以每股
More informationProfitability Improved Greatly; the Worst is Over
- Vinda International (3331 HK) Consumer Sector-Household Products Equity Research 股票研究 Company Report: Vinda International (3331 HK) 公司报告 : 维达国际 (3331 HK) Barney Wu 吴宇扬 (86755) 2397 668 wuyuyang@gtjas.com
More informationNet Margin Improvement on Low Raw Milk Price
: Mengniu Dairy (02319 HK) Sunny Kwok 郭日升 公司报告 : 蒙牛乳业 (02319 HK) +852 2509 2642 sunny.kwok@gtjas.com.hk Margin Improvement on Low Raw Milk Price 原奶价格走低, 净利率有提升空间 GTJA Research 国泰君安研究 Mengniu held a reverse
More informationPositive Long-term Outlook, Upgrade to Accumulate
Sinopharm (01099 HK) Health Care Sector Equity Research 股 票 研 究 公 司 报 告 证 券 研 究 报 告 医药行业 Equity Research Report : Sinopharm (01099 HK) 公司报告 : 国药控股 (01099 HK) [Table_Summary] Positive Long-term Outlook,
More informationChallenges Brought About by Unfavorable Industry Environment on Operations, Downgrade to Neutral
股 票 研 究 公 司 报 告 证 券 研 究 报 告 医 药 行 业 Equity Research Health Care Sector Equity Research Report : Sinopharm (01099 HK) Kay Mai 麦梓琪 公司报告 : 国药控股 (01099 HK) +86755 2397 6685 maiziqi@gtjas.com Challenges Brought
More informationMarket Pressure Remains, Reiterate Neutral
: Prada (01913 HK) Terry Hong 洪学宇公司报告 : 普拉达 (01913 HK) +86 755 23976722 hongxueyu@gtjas.com Market Pressure Remains, Reiterate Neutral 市场压力仍在持续, 重申 中性 GTJA Research 国泰君安研究 Increasing presence in social
More informationA Fresh Start in 2018 as Amoeba Model is on Track
- Consumer Sector-Household Products Equity Research 股票研究 Company Report: 公司报告 : 恒安国际 (144 HK) Barney Wu 吴宇扬 (86755) 2397 668 wuyuyang@gtjas.com 公 司 报 告 证 券 研 究 报 告 消费行业 日用品 Equity Research Report Company
More informationEarnings in 1H2018 Surprised, Upgrade to "Buy"
- Singyes Solar (75 HK) Clean Energy Sector Solar Equity Research 股票研究 Company Report: Singyes Solar (75 HK) 公司报告 : 兴业太阳能 (75 HK) Earnings in 1H218 Surprised, Upgrade to "Buy" 218 上半年盈利超预期, 上调至 买入 Jun
More informationStatic on the line CHINA TELECOM (728:HK)
17-04 17-05 17-06 17-07 17-08 17-09 17-10 17-11 17-12 18-01 18-02 18-03 18-04 本研究报告仅通过邮件提供给国投瑞银国投瑞银基金管理有限公司 (res@ubssdic.com) 使用 1 SWS Co. Ltd is a subsidiary of Shenwan Hongyuan Securities. 99 East Nanjing
More information业绩如期,2015 年车型升级. Hold Downgrade 吉利汽车 (175:HK) Automobiles Company Research. Bringing China to the World
SWS Research Co. Ltd is a subsidiary of Shenwan Hongyuan Securities. 99 East Nanjing Road, Shanghai +86 21 2329 7818 www.swsresearch.com Automobiles Company Research Bringing China to the World 19 March
More information杠杆之殇. Bringing China to the World. New Energy Company Research. 下调 GCL New Energy (451HK) Market Data: Aug 29, 2018
SWS Co. Ltd 99 East Nanjing Road, Shanghai +86 21 2329 7818 www.swsresearch.com Bringing China to the World New Energy Company 30 Aug 2018 中性 杠杆之殇 下调 GCL New Energy (451HK) Market Data: Aug 29, 2018 Financial
More informationNon-Acoustics will be the Main Driver in FY17, Buy 非声学产品将成为 2017 财年的主要驱动力, 买入
(2618 HK)(2618 HK) 派集团 (2618 HK) GTJA Research 国泰君安研究 Company Report: AAC Tech (218 HK) Ricky Lai 黎柏坚 公司报告 : 瑞声科技 (218 HK) +852 259 263 ricky.lai@gtjas.com.hk Non-Acoustics will be the Main Driver in FY17,
More informationStrong Contracted Sales But High Leverage Ratio, Maintain Accumulate
: Evergrande (3333 HK) Van Liu 刘斐凡公司报告 : 中国恒大 (3333 HK) +86 755 2397 6672 liufeifan@gtjas.com Strong Contracted Sales But High Leverage Ratio, Maintain Accumulate 强劲的合约销售但很高的杠杆比率, 维持 收集 The Company s contracted
More informationACCA F3/FIA FFA. Provided by Academy of Professional Accounting (APA) Financial Accounting(FA) Financial Reporting ACCA Lecturer: Tom Liu
Professional Accounting Education Provided by Academy of Professional Accounting (APA) ACCA F3/FIA FFA Financial Accounting(FA) Financial Reporting ACCA Lecturer: Tom Liu ACCAspace 中国 ACCA 特许公认会计师教育平台
More information加码高端物管市场维持彩生活买入评级 彩生活服务集团 (1778:HK) BUY Unchanged. Real Estate Company Research. Bringing China to the World
15-08 15-09 15-10 15-11 15-12 16-01 16-02 16-03 16-04 16-05 16-06 16-07 16-08 SWS Research Co. Ltd is a subsidiary of ShenwanHongyuan Securities. 99 East Nanjing Road, Shanghai +86 21 2329 7818 www.swsresearch.com
More information环境险峻 京东集团 (JD:US) 中性维持. Bringing China to the World. Internet Software &Services Company Research
本研究报告仅通过邮件提供给国投瑞银国投瑞银基金管理有限公司 (res@ubssdic.com) 使用 1 SWS Co. Ltd 99 East Nanjing Road, Shanghai +86 21 2329 7818 www.swsresearch.com Internet Software &Services Company Bringing China to the World 2018
More information株洲南车时代电气 ( 3898.HK ) 中报业绩显示环比改善迹象
本研究报告仅通过邮件提供给泰信基金朱志权 (zhuzhiquan@ftfund.com) 使用 1 wwwww1 SWS Research Co. Ltd 99 East Nanjing Road, Shanghai +86 21 2329 7818 www.swsresearch.com Capital Goods Company Research The Chinese View on China
More informationSales Trend Remains Strong, Maintain Buy
Consumer Sector Retailing Equity Research Report Company Report Equity Research 股票研究 Company Report: Andrew Song 宋涛 公司报告 : 海尔电器 (01169 HK) +852 2509 5313 andrew.song@gtjas.com.hk Sales Trend Remains Strong,
More information2015年度审计报告及财务报表 02 03
2015年度审计报告及财务报表 02 03 2015 年度审计报告及财务报表 04 05 资产负债表 单位 : 中国石化财务有限责任公司 金额单位 : 元 资产行次 2015-12-31 2014-12-31 负债及所有者权益行次 2015-12-31 2014-12-31 资产 : 1 负债 : 52 现金 2 200,861.73 192,601.71 拆入资金 53 10,000,000,000.00
More information主要催化双双延期 金山软件 (3888:HK) 增持维持. Bringing China to the World. Internet Software &Services Company Research
本研究报告仅通过邮件提供给国投瑞银国投瑞银基金管理有限公司 (res@ubssdic.com) 使用 1 SWS Co. Ltd 99 East Nanjing Road, Shanghai +86 21 2329 7818 www.swsresearch.com Internet Software &Services Company Bringing China to the World 2018
More informationNoodles Recovered, but Challenges in Beverages Remain
- Consumer Sector-Food & Beverage Equity Research 股票研究 Company Report: 公司报告 : 康师傅 (00322 HK) Barney Wu 吴宇扬 (86755) 2397 6680 wuyuyang@gtjas.com Noodles Recovered, but Challenges in Beverages Remain 方便面复苏,
More informationExciting Future Ahead, Reiterate Buy
Geely Automobile (00175 HK) Automobiles & Components Sector Equity Research 股票研究 : Geely Automobile (00175 HK) 公司报告 : 吉利汽车 (00175 HK) Exciting Future Ahead, Reiterate Buy 前程似锦, 重申 买入 Toliver Ma 马守彰 (852)
More information经营稳健, 新并购落地. BUY Unchanged. Pharmaceuticals, Biotechnology & Life Company. Bringing China to the World. Analyst
17-03 17-04 17-05 17-06 17-07 17-08 17-09 17-10 17-11 17-12 18-01 18-02 SWS Co. Ltd 99 East Nanjing Road, Shanghai +86 21 2329 7818 www.swsresearch.com Pharmaceuticals, Biotechnology & Life Company Bringing
More informationImproving fundamentals LEE & MAN PAPER MANUFACTURING (2314:HK) Financial summary and valuation
本研究报告仅通过邮件提供给国投瑞银国投瑞银基金管理有限公司 (res@ubssdic.com) 使用 1 SWS Co. Ltd is a subsidiary of Shenwan Hongyuan Securities. 99 East Nanjing Road, Shanghai +86 21 2329 7818 www.swsresearch.com Materials Company 1
More informationUncertain Domestic Demand in 2019, Maintain "Neutral"
Xinyi Solar (00968 HK) Clean Energy Sector Solar Equity Research 股票研究 : Xinyi Solar (00968 HK) 公司报告 : 信义光能 (00968 HK) Jun Zhu 朱俊杰 (852) 2509 7592 junjie.zhu@gtjas.com.hk Uncertain Domestic Demand in 2019,
More information流动性补充 配股将最多为华油能源带来约 2.3 亿港币现金 (1.9 亿人民币 ), 相当于 17 年底在手现金的 1.3 倍 获得的流动性补充不仅满足了在订单量激增下日益增长的项目垫资需求, 而且在行业景气周期中为企业未来业务发展打下了坚实的资金基础, 打开了未来的增长空间
本研究报告仅通过邮件提供给国投瑞银国投瑞银基金管理有限公司 (res@ubssdic.com) 使用 1 SWS Co. Ltd is a subsidiary of Shenwan Hongyuan Securities 99 East Nanjing Road, Shanghai (8621)23297818 www.swsresearch.com Utilities Bringing China
More information1 欧美经济增长数据好于预期, 但次贷阴影远未消除, 美国经济衰退的可能性仍然较大 月初, 标准普尔下调了雷曼兄弟 美林和摩根士丹利三大华尔街投资银行的信用评级, 另外, 标普还将美美国银行 摩根大通的评级展望由稳定下调至负面
一 宏观经济 ( 一 ) 国际经济形势 1 欧美经济增长数据好于预期, 但次贷阴影远未消除, 美国经济衰退的可能性仍然较大 2018-01 美国将 1 季度 GDP 增速由 0.6% 向上修修正至 0.9%, 主要由净出口带动 : 净出口贡献率从 0.2 个百分点上调至 0.8 个百分点 5 月制造业指数从 4 月份的 48.6 升至 49.6, 略高于市场预预期 欧元区一季度 GDP 季调后季比增长
More information中国中铁 -H [390.HK] 中国建筑业 收盘价 : 7.19 港元 (2018 年 11 月 30 日 ) 目标价 : 8.30 港元 (+15.4%) 股价表现 (852)
中国中铁 -H [390.HK] 继续看好 2019 年盈利增长前景我们已更新了公司的 2018-2019 年盈利预测 公司 18 年首九个月的净利润同比增长 18.2%, 同期整体基础设施投资增长则基本持平 凭借中央国有企业建筑公司的地位, 公司在 18 年首九个月成功获得市场份额, 亦增加了对利润率较高的 PPP 投资业务的规模 面对经济增长下行的强大压力, 中央政府将明显依靠基础设施固定资产投资来稳定经济增长
More information业绩符合预期 交行周四公布中报业绩 期末贷款余额同比增长 7.4%, 存款余额同比增长 4.9% 净息差同比下降 30 个基点至 1.97% 净利息收入同比下降 4.1%, 非利息收入同比增速达到 8.1% 上半年净利润达到 亿元, 基本每股收益 0.
SWS Research Co. Ltd is a subsidiary of Shenwan Hongyuan Securities. 99 East Nanjing Road, Shanghai +86 21 2329 7818 www.swsresearch.com Bringing China to the World August 26, 2016 买入 维持 Market Data: Aug
More informationOvervalued communication tower infrastructure service provider
ChinaTower (788.HK) 3 th Jan 219 Target Price(HKD) 1.36 29 th Jan 219 1.67 Close Price 1.67 HSI 2762.85 52-Week Range.99/1.76 Market Cap(HKDm) 293,93 3-mth ave. T/O(HKDm) 1.3 Auditor Data source:bloomberg
More informationVinda(3331.HK) A fair deal for Vinda shareholders. Company Research
Company Research 05 November 2013 Vinda(3331.HK) A fair deal for Vinda shareholders SCA s cash offer of HK$11/share for Vinda had become unconditional. Post acquisition, we believe SCA will reap immediate
More informationCSE: LUX XETRA: NGO Frankfurt: NGO. Environmentally Responsible Gold Recovery
CSE: LUX XETRA: NGO Frankfurt: NGO Environmentally Responsible Gold Recovery Cautionary Disclaimer Forward Looking Statements Certain statements contained herein regarding Newlox Gold Ventures Corp. (the
More information迎头赶上. Bringing China to the World. Automobiles Company Research. Related Reports GWM (2333:HK)-Engine restart August 28, 2017 投资要点 : 29 September 2017
SWS Co. Ltd is a subsidiary of Shenwan Hongyuan Securities 99 East Nanjing Road, Shanghai +862123297818 www.swsresearch.com Bringing China to the World 29 September 2017 买入 维持 Market Data: 28 September
More informationChina Economics. Macro Research. sense. Hence, there is still a long way to go for its yoy growth to turn positive. under the present situation.
China Economics CPI ticks higher statistically while PPI still in a downward trend The March CPI grew 2.4 yoy due to the tail raising factor and seasonality. As the mom growth of food prices decreased
More informationTse Sui Luen(417.HK) Company Research. Non-rated. 30 Oct 2013
Company Research 30 Oct 2013 Tse Sui Luen(417.HK) Room for improvement From a low base, Tse Sui Luen (TSL) reported a strong 55% growth in net profit to HK$47.6m for the interim ended 31 st August 2013.
More information全面进入 EMC 模式 同方泰德 (1206:HK) BUY. Technology Hardware & Equipment Company. Bringing China to the World. Unchanged
SWS Co. Ltd is a subsidiary of ShenwanHongyuan Securities. 99 East Nanjing Road, Shanghai +86 21 2329 7818 www.swsresearch.com Technology Hardware & Equipment Company Bringing China to the World 2 June
More informationWeekly HKFRS Q&As Q&A # 7
China National Technical Weekly HKFRS Q&As Q&A # 7 中文 March 2014 Since January 2014, we started to publish weekly HKFRS Q&As that aim to help you deal with the application issues during the busy financial
More informationMain Beneficiary of One Belt, One Road Initiative, Maintain Accumulate 一带一路 计划的主要受益者, 维持 收集. Profitability Undermined by Falling Wafer ASP, Neutral
Equity Research 股票研究 Research Department 今晨焦点证券研究报告 Equity Research Report Table of Contents 目录 Weekly Overview and Trading Focus 上周回顾和本周交易提示 Upcoming key economic data and events 即将公布的重要经济数据和事件 Industry
More informationORI for the 2 nd Quarter of 2015 概要 2015 年二季度末中国银行离岸人民币指数 (ORI) 为 1.37%, 较一季度末上升 0.1 个百分点
ORI for the 2 nd Quarter of 2015 概要 2015 年二季度末中国银行离岸人民币指数 (ORI) 为 1.37%, 较一季度末上升 0.1 个百分点 与上季度相比, 二季度人民币兑美元汇率保持稳定 ; 境内外利差保持在较窄区间 ; 离岸金融市场整体金融活动规模继续回落, 人民币在离岸金融市场的使用规模及使用份额提升 境外存款总量中, 人民币存款份额回升 人民币债券融资再度活跃
More information年报前瞻 中广核新能源 (1811:HK) Renewable Energy Company. Bringing China to the World
本研究报告仅通过邮件提供给方正富邦基金方正富邦基金管理有限公司 (research@founderff.com) 使用 1 SWS Co. Ltd is a subsidiary of Shenwan Hongyuan Securities. 99 East Nanjing Road, Shanghai +86 21 2329 7818 www.swsresearch.com Renewable Energy
More informationR&D tax incentives in the EU 欧盟的研发税收奖励
R&D tax incentives in the EU 欧盟的研发税收奖励 By Vinod Kalloe Head of international tax policy KPMG The Netherlands 荷兰毕马威会计事务所国际税收政策部负责人 IP Key-CAS IPM Conference Beijing, 4 December 2014 北京,2014 年 12 月 4 日 Content
More informationNature and sustainability of the Chinese economy
Nature and sustainability of the Chinese economy Long Guoqiang Development Research Center of the State Council Prepared for the Nomura Foundation Conference Prospects for Growth in the World s Four Major
More information1Q17 Results Beat Expectations, Strong Online Games, Buy 2017 年第 1 季度业绩超预期, 在线游戏强劲, 买入
Internet Sector Equity Research 股票研究 Company Report: Ricky Lai 黎柏坚 公司报告 : 腾讯控股 (00700 HK) +852 2509 2603 ricky.lai@gtjas.com.hk 1Q17 Results Beat Expectations, Strong Online Games, Buy 2017 年第 1 季度业绩超预期,
More informationWeaker Monetization from New Games, "Buy"
Tencent (00700 HK) Internet Sector Equity Research 股票研究 Company Report: Tencent (00700 HK) 公司报告 : 腾讯控股 (00700 HK) Weaker Monetization from New Games, "Buy" 新游戏的货币化进度较弱, 买入 Ricky Lai 黎柏坚 (852) 2509 2603
More information7%). 我们将目标价从 16 港币提高至 18.5 港币, 对应 14.5x 17 年 PE 对应约 24.2% 上行空间 我们维持买入评级
SWS Co. Ltd is a subsidiary of Shenwan Hongyuan Securities. 99 East Nanjing Road, Shanghai +86 21 2329 7818 www.swsresearch.com Technology Industry Company Bringing China to the World 31 May 2017 BUY Unchanged
More informationCompany Research. Not Rated
Company Research Sept 4, 2013 China Ruifeng(527.HK) Transforming into a wind farm operator China Ruifeng Renewable Energy Hldg. Ltd. (527.hk) is currently transforming into a wind farm operator, after
More informationFurther Enhancements in Valuation Still Feasible from Potential ROE Expansion, Maintain Buy 潜在的净资产收益率扩张导致进一步估值中枢增长仍然可期, 维持 买入
Anhui Conch (914 HK) Cement and Construction Materials Sector Equity Research 股票研究 Company Report: Anhui Conch (914 HK) 公司报告 : 安徽海螺 (914 HK) Sean Xiang 向宇豪 (86755) 2397 6725 xiangyuhao@gtjas.com [Table_Summary]
More informationFINANCIAL STATEMENT AND RELATED ANNOUNCEMENT
FINANCIAL STATEMENT AND RELATED ANNOUNCEMENT https://www1.sgxnet.sgx.com/sgxnet/lcanncsubmission.nsf/vwprint/bb0a31278a988363482579... Page 1 of 1 27-Feb-2012 Print this page Full Year Results * Financial
More informationMonex Securities Schedule of Fees and Charges. Monex Brokerage Fees. Monex Securities Australia Pty Ltd AFSL No: ABN:
Monex Securities Schedule of Fees and Charges Monex Brokerage Fees Markets Brokerage Fee *1 Settlement Currency *2 United States New York Stock Exchange (NYSE) NASDAQ Australia *3 Australian Stock Exchange
More informationA Fast Growing Property Developer, Initiate with "Buy"
Ronshine China (331 HK) Property Sector Equity Research 股票研究 Company Report: Ronshine China (331 HK) 公司报告 : 融信中国 (331 HK) A Fast Growing Property Developer, Initiate with "Buy" 一家快速增长的地产开发商, 首予 买入 Van
More informationLee'S Pharm (950 HK) Company Research Company visit. 24 July 2014 Non rated HK$10.28
Company Research Company visit Leveraging global opportunities By our latest talking with Dr. Li, we were impressed by Lee s pharm s drug pipeline. The international background of key shareholders has
More informationAnalysis. ORI for the 3 rd Quarter of 2017 概要 2017 年三季度末中国银行离岸人民币指数 (ORI) 为 1.22%, 较上季度末微升 0.03 个百分点, 超出预测值 0.04 个百分点
ORI for the 3 rd Quarter of 2017 概要 2017 年三季度末中国银行离岸人民币指数 (ORI) 为 1.22%, 较上季度末微升 0.03 个百分点, 超出预测值 0.04 个百分点 离岸市场人民币存款规模继续回升 ; 贷款及融资活动有所下降 ; 境内资本市场开放继续带动离岸市场人民币计价权益类投资 Main Points The BOC Off-shore RMB
More informationProperties Sector: Minimum Down payment Increase in Shanghai and Tianjin
Morning Research Department Table of Contents 目录 29 November 2016 Industry and Company Focus 行业和公司焦点 Samsonite (01910 HK): 3Q16 Financial Results Met Expectations 新秀丽 (01910 HK):2016 年 3 季度财务数据符合预期 Properties
More informationSustainable Growth Supported By Many Factors, Buy
GTJA Research 国泰君安研究 Company Report: Tong Ren Tang Technologies (01666 HK) Johnson Sun 孙凤强 公司报告 : 同仁堂科技 (01666 HK) +852 25097589 johnson.sun@gtjas.com.hk Sustainable Growth Supported By Many Factors, Buy
More information中集安瑞科控股有限公司 (03899.HK)
公司报告 中集安瑞科控股有限公司 (03899.HK) 股价充分反映天然气汽车概念 我们把中集安瑞科 ( 集团 或 安瑞科 ) 的评级由 买入 下调至 中性 目前股价已接近我们根据分类加总值法 (SOTP) 而计算出的目标价, 而对应的市盈率较更历史平均值高逾一个标准差 我们认为其股价已充分反映政府推动以天然气取代石油的利好因素 天然气加气站的供大于求对设备销售加快形成矛盾在使用天然气作为汽车燃料的主要国家中,
More informationAnalysis. ORI for the 2 nd Quarter of 2017 概要 2017 年二季度末中国银行离岸人民币指数 (ORI) 为 1.19%, 较上季度末微升 0.02 个百分点, 符合前期预测. Main Points
ORI for the 2 nd Quarter of 2017 概要 2017 年二季度末中国银行离岸人民币指数 (ORI) 为 1.19%, 较上季度末微升 0.02 个百分点, 符合前期预测 人民币在离岸权益类资产 贷款及外汇储备等方面的使用水平提升 ; 境外及非居民人民币存款总量经历七个季度回落后首次上升 ; 离岸人民币指数保持回稳态势 Main Points The BOC Off-shore
More informationAccount Maintenance Fee. USD 10 or equivalent per month for average account balance(s) less than USD 100,000 or equivalent. Account Maintenance Fee
Charges and Commissions (Effective from 1 st October, 2015) Account Maintenance Fee Account Maintenance Fee USD 10 or equivalent per month for average account balance(s) less than USD 100,000 or equivalent.
More informationA-Share Securities Sector
Equity Research Financials AShare Securities Sector Trading recovered; 19 listed brokers saw May net profit up 24% Ou Yafei SFC CE No. BFN410 oyf@gf.com.cn +86 20 8757 3009 GF Securities (Hong Kong) Brokerage
More information芯系天下 ( 線上法說會 ) Q Quarterly Online Investor Conference. March 15, March 3, 2016
環宇 芯系天下 March 3, 2016 Q4 2018 Quarterly Online Investor Conference ( 線上法說會 ) March 15, 2019 Disclaimer Statement This presentation includes forward-looking statements. All statements, other than statements
More informationATA Inc. Financial Results Conference Call for the Three- and Nine-Month Transition Periods Ended December 31, 2017 TRANSCRIPT
ATA Inc. Financial Results Conference Call for the Three- and Nine-Month Transition Periods Ended December 31, 2017 TRANSCRIPT March 19, 2018 at 9 p.m. ET SPEAKERS Carolyne Sohn Senior Associate, The Equity
More informationChapter 24 Credit Risk
Chapter 24 Credit Risk 郑振龙厦门大学金融系课程网站 :http://efinance.org.cn Email: zlzheng@xmu.edu.cn 1 Credit Ratings In the S&P rating system, AAA is the best rating. After that comes AA, A, BBB, BB, B, CCC, CC, and
More informationCAR Inc Annual Results. Feb 27 th, 2018
CAR Inc. 2017 Annual Results Feb 27 th, 2018 Operational & Financial Highlights Q4 17 Highlights (RMB in millions) Car rental 1,211 684 Continue to demonstrate strong growth momentum with YOY price reduction
More informationThe Yuan Exchange rate and Firms Atturo Giulia
1 The yuan exchange rate and firms How the Chinese exchange rate can influence strategic entering into the Chinese market Abstract 中国人民币汇率跟企业的关系 随着时代的进步, 国与国的距离拉近, 各国间政府, 经济, 文化等方面的常常交流, 全球化已经到了 外贸经济的地位越来越紧要,
More informationCrude Oil Price Outlook
Crude Oil Price Outlook Positivity from risk appetite, supply-demand structure and Middle East tensions Minggao Shen SFC CE No. ATQ771 minggaoshen@gfgroup.com.hk +852 3719 1055 GF Securities (Hong Kong)
More informationGuosen Expert Series: Accounting and Regulatory Challenges to VIEs in China
Sector Research Guosen Expert Series: Accounting and Regulatory Challenges to VIEs in China A massive migration of US listed Chinese companies to HK? Alibaba s (Not Listed) long-awaited IPO has put the
More information中国人民银行上海总部关于支持中国 ( 上海 ) 自由贸易试验区扩大人民币跨境使用的通知
Unofficial Translation 中国人民银行上海总部关于支持中国 ( 上海 ) 自由贸易试验区扩大人民币跨境使用的通知 Notice of the Shanghai Head Office of the People's Bank of China to Promote Cross-border Use of Renminbi in the China (Shanghai) Pilot
More informationSunny Optical (2382 HK)
Equity Research Tech Hardware Optical (2382 HK) Industry leadership continues to strengthen on optical and optoelectronic products Ou Yafei SFC CE No. BFN41 oyf@gf.com.cn +86 2 8757 39 GF Securities (Hong
More informationKey Topics on China -Venezuela Business 中国 - 委内瑞拉投资关键考虑. Tax overview July 2011 税务概述 2011 年 7 月. Espiñeira, Sheldon y Asociados1
Key Topics on China -Venezuela Business 中国 - 委内瑞拉投资关键考虑 Tax overview July 2011 税务概述 2011 年 7 月 1 Agenda 目录 Choice of entity Registrations Restrictions on cross-border cash flows Key tax issues Individual
More informationMedia Announcement (For Immediate Release) 即时新闻发布. LionGold Corp Signs MOU with China SOE-backed Mining Contractor 瑞狮集团和中国国有企业背景的矿山工程承包商 签订合作备忘录
LionGold Corp Ltd (Incorporated in Bermuda) 59 Mohamed Sultan Road Sultan Link 02-08 Singapore 238999 Tel: (65) 6690 6860 Fax: (65) 6690 6844 info@liongoldcorp.om www.liongoldcorp.com LIONGOLD CORP Highlights
More information绿城服务集团 (2869:HK) 中期业绩符合预期增长有质有量 扩张稳中有进 截至 6 月末, 公司产生收入的总在管合同建筑面积从去年年中的 6900 万方增长至 9140 万方 ( 同比增长 32.5%), 同期储备合同面积从
07/2016 07/2016 07/2016 Fortune Cookies Company visit Not Rated Greentown Service Group Co Ltd Sector: Industrials Industry: Commercial Services & Supplies Sub-industry: Diversified Support Services Key
More information2H18 Hong Kong TMT Sector Outlook
Equity Research TMT 2H18 Hong Kong TMT Sector Outlook Optical leaders benefiting from increased penetration of dual-cameras and 3D sensing; semiconductors to enter development upcycle Ou Yafei SFC CE No.
More informationACCA IFRS Seminar in Shenzhen 16 September 2006
ACCA IFRS Seminar in Shenzhen 16 September 2006 IFRS Nelson Lam CFA FCCA FCPA(Practising) MBA MSc BBA CPA(US) ACA 2005-06 Nelson 1 Today s Agenda Introduction Presentation and Disclosure IFRS and PRC GAAP
More informationNagacorp Ltd (3918 HK)
Company Research Company update An emerging market game NagaCorp is the only Cambodian company listed in Hong Kong. It is under a monopoly guarantee and operates a casino in Phnom Penh. The unique location
More informationCHINA BUSINESS CLIMATE SURVEY REPORT
CHINA BUSINESS CLIMATE SURVEY REPORT 中国商务环境调查报告 The American Chamber of Commerce in the People s Republic of China In partnership with 与贝恩公司合作编制 Table of Contents 目录 Chairman's Message 2 主席致辞 Executive
More informationINVEST TO SUCCEED. INVEST TORONTO CCBC RECEPTION
INVEST TO SUCCEED. INVEST TORONTO CCBC RECEPTION INVEST TORONTO 多伦多投资促进局 Invest Toronto is your connection to the global business opportunities found in Toronto. We can facilitate all of the government
More informationIGG (799 HK) Company Research Non-rated note. 17 May 2017 Non rated N/A
Company Research Non-rated note Back in the game IGG s FY16 net profit jumped stunningly at 74%yoy to USD72m, on the launch of Lords Mobile (LM) from Mar-2016. We see LM sales will likely overwhelm IGG
More informationWeek 1: Financial reporting requirements & Conceptual Framework 1. Disclosing entity: 2. Proprietary company: 3. Public company: annual
Week 1: Financial reporting requirements & Conceptual Framework 3 types of entities: 1. Disclosing entity: An entity whose securities are listed on securities exchange 2. Proprietary company: Can, cannot,
More information2 KPlas Holdings Limited annual report Contents
annual report 007 2 KPlas Holdings Limited annual report Contents 01 Corporate Profile 02 Chairman s & Managing Director s Message 04 Profile of Directors 05 Management Team 05 Corporate Structure 06 Corporate
More information5% BONUS 5% 赠金条款 ( 适用于 1 月 ) TERMS AND CONDITIONS
5% BONUS 5% 赠金条款 ( 适用于 1 月 ) TERMS AND CONDITIONS 1 GENERAL 1 总则 The terms and conditions contained herein apply to the Promotional Bonus (the Promotion ) offer made available through the websites of Fair
More informationHFR Industry Reports SAMPLE EXTRACT CONTACT HFR AT OR CALL FOR MORE INFORMATION Copyright 2011 All rights reserved.
2009 www.hedgefundresearch.com ASIAN HEDGE FUND INDUSTRY EXPANDS AS INFLATION BUILDS, JAPAN REBUILDS Hedge Fund Research, Inc. New capital inflows offset performance-based declines in 2Q11; Number of funds
More information中国东方航空股份有限公司 China Eastern Airlines Corporation Limited
中国东方航空股份有限公司 China Eastern Airlines Corporation Limited 股东提名董事候选人程序说明 Procedures for Shareholders to Nominate Director Candidates 第一章总则 Chapter One General Provisions 第一条根据 中华人民共和国公司法 上市公司治理准则 公司章程 关于在上市公司建立独立董事制度的指导意见
More information股市周期可以分为四个泾渭分明的阶段 我们分析了何时盈利增长才会带来高回报 ... 将股市的不同阶段与经济周期联系在一起 股票市场的走势可以分成不同的周期 为了向投资者提供一个参考框架, 我们的分析表明市场从一个高点走向下一个高点的过程可以分成四个泾渭分明的阶段,
29 年 1 月 23 日欧洲 : 投资组合策略股市周期第一部分 : 确认周期的阶段 29 年 1 月 23 日欧洲 : 投资组合策略 股市周期可以分为四个泾渭分明的阶段 股票市场的走势可以分成不同的周期 为了向投资者提供一个参考框架, 我们的分析表明市场从一个高点走向下一个高点的过程可以分成四个泾渭分明的阶段, 我们将这四个阶段分别定义为绝望 希望 增长和乐观 在这个系列研究报告的第一部分中, 我们分析了每个阶段的经济背景和股市回报率的决定因素
More informationPay your ICBC Credit Cards Bills via FAST 通过 FAST 支付工银信用卡账单
Pay your ICBC Credit Cards Bills via FAST 通过 FAST 支付工银信用卡账单 Pay your ICBC Credit Card bills immediately by simply conducting a funds transfer. 您可通过资金转账立即支付工银信用卡账单 ICBC Credit Cards can receive payments
More informationKingsoft Corporation (3888 HK)
Company Research Results Review Kingsoft Corporation (3888 HK) Strong Beat on Mobile Game Expansion Kingsoft s stunning 3Q16 profit surged 151% YoY to RMB304m, 75% above our forecast thanks to stellar
More informationChina Healthcare. A decent world-class denture maker. Company visit note. 20 February 2017
Company visit note China Healthcare A decent world-class denture maker On 13 Feb 2017, we joined the investor tour to visit Modern Dental Group s (MDG) (3600.HK, NR) factory based in Shenzhen. During the
More informationFrequently Asked Questions On Fast Service
第 1 页共 8 页 Frequently Asked Questions On Fast Service 1. What is FAST? FAST (Fast And Secure Transfers) is a new electronic funds transfer service that allows a secure and almost immediate transfer of
More informationA DECADE OF ENABLING BUSINESSES ANNUAL REPORT FY11/12
A DECADE OF ENABLING BUSINESSES ANNUAL REPORT FY11/12 A DECADE OF ENABLING BUSINESSES THE GROWTH RINGS OF A-REIT Growth rings in a tree trunk signify radial growth as the tree produces new layers of wood
More information